If an epitopes library of TNAs with MHC defects was developed and based on the sequence of TNAs with irreversible MHC deficiencies found in patients, the therapeutic impact of customized therapy neoantigen-targeted tumor vaccines or ACT might be dramatically improved. The gene discussed is HLA-C; the disease is neoplasm.